Why the study?
Percutaneous mitral valvuloplasty is widely used for symptomatic rheumatic mitral stenosis, but its short- and mid-term outcomes and the effect of commissural calcifications needed evaluation.
Does the presence of commissural calcification worsen outcomes after percutaneous mitral valvuloplasty in patients with severe mitral stenosis?
Population
961 patients with severe mitral stenosis undergoing PMV
Comparison
Commissural calcification vs no calcification; and Wilkins score subgroups
Design
Retrospective medical record review
Follow-up
24 months
Authors
Loading...
The presence of commissural calcification is associated with higher rates of restenosis and severe mitral regurgitation following percutaneous mitral valvuloplasty.
Does the presence of commissural calcification worsen outcomes after percutaneous mitral valvuloplasty in patients with severe mitral stenosis?
The presence of commissural calcification is associated with higher rates of restenosis and severe mitral regurgitation following percutaneous mitral valvuloplasty.
Mazaherinia et al. (2022) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: